FDA Inspection
Carter BloodCare - LongviewCarter BloodCare - Longview – FDA Inspection, Feb 13, 2025
Record Details
This FDA Inspection record concerns Carter BloodCare - Longview, with an inspection on February 13, 2025, issued by the Dallas District Office, covering biologics.
View Company Profile
ID · 9c051c1a-c8ee-45bd-aecb-7c89c255e842
Inspection Facts
- Inspection number
- 1262070
- FDA center
- Biologics
Other FDA inspections of Carter BloodCare - Longview
5| Date | Classification | Office | Project area |
|---|---|---|---|
| June 5, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 23, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 17, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 5, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 21, 2011 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Carter BloodCare - Longview
- FDA Inspection 1097760 - 2019-06-05
- FDA Inspection 1017197 - 2017-06-23
- FDA Inspection 932717 - 2015-06-17
- FDA Inspection 821700 - 2013-03-05
- FDA Inspection 730855 - 2011-06-21
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.